Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 2
1976 3
1977 1
1978 2
1979 3
1980 5
1981 4
1982 3
1983 4
1984 4
1985 7
1986 6
1987 5
1988 7
1989 10
1990 6
1991 6
1992 7
1993 8
1994 8
1995 10
1996 7
1997 12
1998 6
1999 13
2000 6
2001 8
2002 13
2003 22
2004 9
2005 19
2006 28
2007 19
2008 16
2009 17
2010 26
2011 19
2012 22
2013 14
2014 27
2015 31
2016 27
2017 27
2018 32
2019 44
2020 44
2021 56
2022 61
2023 41
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

706 results

Results by year

Filters applied: . Clear all
Page 1
Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease.
Koide T, Mandai S, Kitaoka R, Matsuki H, Chiga M, Yamamoto K, Yoshioka K, Yagi Y, Suzuki S, Fujiki T, Ando F, Mori T, Susa K, Iimori S, Naito S, Sohara E, Rai T, Yokota T, Uchida S. Koide T, et al. Among authors: yoshioka k. Circ Res. 2023 Feb 17;132(4):415-431. doi: 10.1161/CIRCRESAHA.122.321939. Epub 2023 Jan 26. Circ Res. 2023. PMID: 36700539 Free article.
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC.
Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: yoshioka h. J Thorac Oncol. 2021 Sep;16(9):1523-1532. doi: 10.1016/j.jtho.2021.03.027. Epub 2021 Apr 27. J Thorac Oncol. 2021. PMID: 33915251 Free article. Clinical Trial.
Patients were randomly allocated (1:1) to receive docetaxel (60 mg/m(2)) on day 1 or nab-paclitaxel (100 mg/m(2)) on days 1, 8, and 15 of a 21-day cycle. ...
Patients were randomly allocated (1:1) to receive docetaxel (60 mg/m(2)) on day 1 or nab-paclitaxel (100 mg/m(2)) on days 1, 8 …
Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires.
Yokoi A, Ukai M, Yasui T, Inokuma Y, Hyeon-Deuk K, Matsuzaki J, Yoshida K, Kitagawa M, Chattrairat K, Iida M, Shimada T, Manabe Y, Chang IY, Asano-Inami E, Koya Y, Nawa A, Nakamura K, Kiyono T, Kato T, Hirakawa A, Yoshioka Y, Ochiya T, Hasegawa T, Baba Y, Yamamoto Y, Kajiyama H. Yokoi A, et al. Among authors: yoshioka y. Sci Adv. 2023 Jul 7;9(27):eade6958. doi: 10.1126/sciadv.ade6958. Epub 2023 Jul 7. Sci Adv. 2023. PMID: 37418532 Free PMC article.
High-grade serous ovarian carcinoma (HGSOC) is the deadly subtype of epithelial ovarian cancer, and we aimed to identify HGSOC-specific membrane proteins. Small EVs (sEVs) and medium/large EVs (m/lEVs) from cell lines or patient serum and ascites were analyzed by LC-MS/MS, …
High-grade serous ovarian carcinoma (HGSOC) is the deadly subtype of epithelial ovarian cancer, and we aimed to identify HGSOC-specific memb …
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.
Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M; West Japan Oncology Group. Mitsudomi T, et al. Among authors: yoshioka h. Lancet Oncol. 2010 Feb;11(2):121-8. doi: 10.1016/S1470-2045(09)70364-X. Epub 2009 Dec 18. Lancet Oncol. 2010. PMID: 20022809 Clinical Trial.
METHODS: We did an open label, phase 3 study (WJTOG3405) with recruitment between March 31, 2006, and June 22, 2009, at 36 centres in Japan. 177 chemotherapy-naive patients aged 75 years or younger and diagnosed with stage IIIB/IV non-small-cell lung cancer or postoperative recur …
METHODS: We did an open label, phase 3 study (WJTOG3405) with recruitment between March 31, 2006, and June 22, 2009, at 36 centres in Japan. …
Deep Learning Model for Automated Detection and Classification of Central Canal, Lateral Recess, and Neural Foraminal Stenosis at Lumbar Spine MRI.
Hallinan JTPD, Zhu L, Yang K, Makmur A, Algazwi DAR, Thian YL, Lau S, Choo YS, Eide SE, Yap QV, Chan YH, Tan JH, Kumar N, Ooi BC, Yoshioka H, Quek ST. Hallinan JTPD, et al. Among authors: yoshioka h. Radiology. 2021 Jul;300(1):130-138. doi: 10.1148/radiol.2021204289. Epub 2021 May 11. Radiology. 2021. PMID: 33973835
An internal test set was labeled by a musculoskeletal radiologist with 31 years of experience (reference standard) and two subspecialist radiologists (radiologist 1: A.M., 5 years of experience; radiologist 2: J.T.P.D.H., 9 years of experience). ...
An internal test set was labeled by a musculoskeletal radiologist with 31 years of experience (reference standard) and two subspecialist rad …
Recent Trend of Antimicrobial Susceptibility among Mycoplasma pneumoniae Isolated from Japanese Children.
Oishi T, Yoshioka D, Nakano T, Ouchi K. Oishi T, et al. Among authors: yoshioka d. Microorganisms. 2022 Dec 8;10(12):2428. doi: 10.3390/microorganisms10122428. Microorganisms. 2022. PMID: 36557681 Free PMC article.
Our observation of 122 M. pneumoniae strains suggested that 76 were macrolide-susceptible M. pneumoniae (MSMP) and 46 were macrolide-resistant. ...Therefore, continuation of appropriate antimicrobial use for M. pneumoniae infection is important....
Our observation of 122 M. pneumoniae strains suggested that 76 were macrolide-susceptible M. pneumoniae (MSMP) and 46 were mac …
Generalized Quantum Subspace Expansion.
Yoshioka N, Hakoshima H, Matsuzaki Y, Tokunaga Y, Suzuki Y, Endo S. Yoshioka N, et al. Phys Rev Lett. 2022 Jul 8;129(2):020502. doi: 10.1103/PhysRevLett.129.020502. Phys Rev Lett. 2022. PMID: 35867434
The performance of our method is discussed under two highly practical setups: the quantum subspaces are mainly spanned by powers of the noisy state rho^{m} and a set of error-boosted states, respectively. We numerically demonstrate in both situations that we can suppress e …
The performance of our method is discussed under two highly practical setups: the quantum subspaces are mainly spanned by powers of the nois …
Lethal adulthood myelin breakdown by oligodendrocyte-specific Ddx54 knockout.
Oizumi H, Miyamoto Y, Seiwa C, Yamamoto M, Yoshioka N, Iizuka S, Torii T, Ohbuchi K, Mizoguchi K, Yamauchi J, Asou H. Oizumi H, et al. Among authors: yoshioka n. iScience. 2023 Jul 21;26(10):107448. doi: 10.1016/j.isci.2023.107448. eCollection 2023 Oct 20. iScience. 2023. PMID: 37720086 Free PMC article.
When self-assembly meets interfacial polymerization.
Shen Q, Song Q, Mai Z, Lee KR, Yoshioka T, Guan K, Gonzales RR, Matsuyama H. Shen Q, et al. Among authors: yoshioka t. Sci Adv. 2023 May 3;9(18):eadf6122. doi: 10.1126/sciadv.adf6122. Epub 2023 May 3. Sci Adv. 2023. PMID: 37134177 Free PMC article.
The mechanisms of the formation of crumpled nanostructures were elucidated via multiscale simulations. The electrostatic interactions among m-phenylenediamine (MPD) molecules, surfactant monolayer and micelles, lead to disruption of the monolayer at the interface, which in …
The mechanisms of the formation of crumpled nanostructures were elucidated via multiscale simulations. The electrostatic interactions among …
706 results